{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:18:52Z","timestamp":1790882332641,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005347","name":"AASLD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.aohep.2023.101087","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T02:39:11Z","timestamp":1677983951000},"page":"101087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c"],"prefix":"10.1016","volume":"28","author":[{"given":"Hirsh D.","family":"Trivedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qua","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0512-9359","authenticated-orcid":false,"given":"Jonathan X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.aohep.2023.101087_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2023.101087_bib0002","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.aohep.2023.101087_bib0003","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.aohep.2023.101087_bib0004","first-page":"124","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in united states veterans is associated with non-alcoholic fatty liver disease","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.aohep.2023.101087_bib0005","article-title":"Severe hepatic steatosis by controlled attenuation parameter predicts quality of life independent of fibrosis","author":"Trivedi","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2023.101087_bib0006","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12955-016-0420-z","article-title":"Non-alcoholic Fatty Liver Disease (NAFLD) is associated with impairment of Health Related Quality of Life (HRQOL)","volume":"14","author":"Golabi","year":"2016","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.1016\/j.aohep.2023.101087_bib0007","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1002\/hep.30094","article-title":"Healthcare cost and utilization in non-alcoholic fatty liver disease: real-world data from a large U.S. claims database","volume":"68","author":"Allen","year":"2018","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.aohep.2023.101087_bib0008","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ajg.2014.134","article-title":"Non-alcoholic fatty liver disease is underrecognized in the primary care setting","volume":"110","author":"Blais","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2023.101087_bib0009","article-title":"The impact of non-alcoholic fatty liver disease in primary care: a population health perspective","author":"Dokmak","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.aohep.2023.101087_bib0010","article-title":"Serial transient elastography examinations to monitor patients with type 2 diabetes: a prospective cohort study","author":"Lee","year":"2020","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.aohep.2023.101087_bib0011","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-019-1321-x","article-title":"Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts","volume":"17","author":"Alexander","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.aohep.2023.101087_bib0012","article-title":"Diabetes is associated with increased risk of hepatocellular carcinoma in cirrhosis patients with non-alcoholic fatty liver disease","author":"Yang","year":"2019","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.aohep.2023.101087_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100336","article-title":"The presence of diabetes impacts liver fibrosis and steatosis by transient elastography in a primary care population","volume":"24","author":"Trivedi","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2023.101087_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121185","article-title":"Shedding light on non-alcoholic fatty liver disease: pathogenesis, molecular mechanisms, models, and emerging therapeutics","volume":"312","author":"Khairnar","year":"2023","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.aohep.2023.101087_bib0015","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep4.1501","article-title":"Differential associations of circulating microRNAs with pathogenic factors in NAFLD","volume":"4","author":"Ezaz","year":"2020","journal-title":"Hepatol Commun"},{"issue":"11","key":"10.1016\/j.aohep.2023.101087_bib0016","doi-asserted-by":"crossref","first-page":"e76161","DOI":"10.1371\/journal.pone.0076161","article-title":"Glycemic variability is an independent predictive factor for development of hepatic fibrosis in non-alcoholic fatty liver disease","volume":"8","author":"Hashiba","year":"2013","journal-title":"PLOS One"},{"issue":"Suppl 1","key":"10.1016\/j.aohep.2023.101087_bib0017","first-page":"S7","article-title":"Improving care and promoting health in populations: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.aohep.2023.101087_bib0018","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/hep4.1603","article-title":"Elevated glycated hemoglobin is associated with liver fibrosis, as assessed by elastography, in a population-based study of Mexican Americans","volume":"4","author":"Watt","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2023.101087_bib0019","article-title":"Fibrosis-4 index as an independent predictor of mortality and liver-related outcomes in NAFLD","author":"Vieira Barbosa","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2023.101087_bib0020","doi-asserted-by":"crossref","DOI":"10.14309\/ajg.0000000000001606","article-title":"Fibrosis-4 index can independently predict major adverse cardiovascular events in nonalcoholic fatty liver disease","author":"Vieira Barbosa","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2023.101087_bib0021","doi-asserted-by":"crossref","DOI":"10.5009\/gnl210391","article-title":"Accuracy of non-invasive scoring systems in assessing liver fibrosis in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","author":"Han","year":"2022","journal-title":"Gut Liver"},{"key":"10.1016\/j.aohep.2023.101087_bib0022","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis","author":"M\u00f3zes","year":"2021","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.aohep.2023.101087_bib0023","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep4.1411","article-title":"Impact of implementing a \u201cFIB-4 first\u201d strategy on a pathway for patients with NAFLD referred from primary care","volume":"3","author":"Davyduke","year":"2019","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.aohep.2023.101087_bib0024","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","article-title":"Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease","volume":"71","author":"Srivastava","year":"2019","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.aohep.2023.101087_bib0025","doi-asserted-by":"crossref","first-page":"e00473","DOI":"10.14309\/crj.0000000000000473","article-title":"An algorithmic approach to NAFLD screening: from PCP to specialist","volume":"7","author":"Trivedi","year":"2020","journal-title":"ACG Case Rep J"},{"issue":"1","key":"10.1016\/j.aohep.2023.101087_bib0026","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.aohep.2023.101087_bib0027","article-title":"Impact of type 2 diabetes on the accuracy of noninvasive tests of liver fibrosis with resulting clinical implications","author":"Boursier","year":"2022","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"1","key":"10.1016\/j.aohep.2023.101087_bib0028","first-page":"216","article-title":"Development and validation of hepamet fibrosis scoring system-a simple, noninvasive test to identify patients with non-alcoholic fatty liver disease with advanced fibrosis","volume":"18","author":"Ampuero","year":"2020","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"5","key":"10.1016\/j.aohep.2023.101087_bib0029","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123001916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123001916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:45:58Z","timestamp":1761648358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268123001916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1665268123001916"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101087","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes complications are associated with liver fibrosis independent of hemoglobin A1c","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101087"}}